AP-1 transcription factors, mucin-type molecules and MMPs regulate the IL-11 mediated invasiveness of JEG-3 and HTR-8/SVneo trophoblastic cells

PLoS One. 2012;7(1):e29745. doi: 10.1371/journal.pone.0029745. Epub 2012 Jan 3.

Abstract

This study examines the IL-11 mediated activation of downstream signaling and expression of effector molecules to resolve the controversies associated with the IL-11 mediated regulation of the invasiveness of two commonly used trophoblastic cell models viz. JEG-3 and HTR-8/SVneo cells. It has been reported that IL-11 increases the invasiveness of JEG-3 cells while, reduces the invasiveness of HTR-8/SVneo cells. Invasion assay performed simultaneously for both the cell lines confirmed the above findings. In addition, HTR-8/SVneo cells showed a higher basal invasiveness than JEG-3 cells. Western blot showed the IL-11 mediated activation of STAT3(tyr705) and STAT1(tyr701) in both the cell lines. However, IL-11 activated the ERK1/2 phosphorylation in JEG-3 cells but, inhibited it in HTR-8/SVneo cells. Within 10 min of IL-11 treatment, p-STAT3(tyr705) was localized inside the nucleus of both the cell lines but, there was enhanced co-localization of protein inhibitor of activated STAT1/3 (PIAS1/3) and p-STAT3(tyr705) in HTR-8/SVneo cells and not in JEG-3 cells. This could be reason for the poor responsiveness of STAT3 responsive genes like mucin 1 (MUC1) in HTR-8/SVneo cells and not in JEG-3 cells. Further, microarray analysis of the IL-11 treated cells revealed differential responsiveness of JEG-3 as compared to HTR-8/SVneo cells. Several family of genes like activator protein-1 (AP-1) transcription factors (Jun and Fos), mucin-type molecules, MMP23B etc showed enhanced expression in IL-11 treated JEG-3 cells while, there was no response or decrease in their expression in IL-11 treated HTR-8/SVneo cells. Expression of these molecules was confirmed by quantitative RT-PCR. In addition, HTR-8/SVneo cells also showed a significant decrease in the expression of MMP2, MMP3 and MMP9 upon IL-11 treatment. Hence, IL-11 mediated differential activation of signaling and expression of effector molecules is responsible for the differential invasive response of JEG-3 and HTR-8/SVneo cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Active Transport, Cell Nucleus / drug effects
  • Cell Line, Tumor
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Embryo Implantation / drug effects
  • Gene Expression Regulation, Developmental / drug effects
  • Gene Silencing
  • Humans
  • Integrins / genetics
  • Integrins / metabolism
  • Interleukin-11 / pharmacology*
  • Matrix Metalloproteinases / deficiency
  • Matrix Metalloproteinases / genetics
  • Matrix Metalloproteinases / metabolism*
  • Membrane Glycoproteins / genetics
  • Membrane Glycoproteins / metabolism
  • Molecular Chaperones / metabolism
  • Mucin-1 / genetics
  • Mucin-1 / metabolism
  • Mucins / metabolism*
  • Phosphoproteins / metabolism
  • Protein Inhibitors of Activated STAT / genetics
  • Protein Inhibitors of Activated STAT / metabolism
  • STAT3 Transcription Factor / metabolism
  • Signal Transduction / drug effects
  • Tissue Inhibitor of Metalloproteinases / genetics
  • Tissue Inhibitor of Metalloproteinases / metabolism
  • Transcription Factor AP-1 / metabolism*
  • Trophoblasts / cytology*
  • Trophoblasts / drug effects*
  • Trophoblasts / metabolism

Substances

  • Integrins
  • Interleukin-11
  • Membrane Glycoproteins
  • Molecular Chaperones
  • Mucin-1
  • Mucins
  • PDPN protein, human
  • PIAS3 protein, human
  • Phosphoproteins
  • Protein Inhibitors of Activated STAT
  • STAT3 Transcription Factor
  • Tissue Inhibitor of Metalloproteinases
  • Transcription Factor AP-1
  • Matrix Metalloproteinases